338 related articles for article (PubMed ID: 28744013)
1. The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.
Girardi T; Vereecke S; Sulima SO; Khan Y; Fancello L; Briggs JW; Schwab C; de Beeck JO; Verbeeck J; Royaert J; Geerdens E; Vicente C; Bornschein S; Harrison CJ; Meijerink JP; Cools J; Dinman JD; Kampen KR; De Keersmaecker K
Leukemia; 2018 Mar; 32(3):809-819. PubMed ID: 28744013
[TBL] [Abstract][Full Text] [Related]
2. The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.
Kampen KR; Sulima SO; Verbelen B; Girardi T; Vereecke S; Rinaldi G; Verbeeck J; Op de Beeck J; Uyttebroeck A; Meijerink JPP; Moorman AV; Harrison CJ; Spincemaille P; Cools J; Cassiman D; Fendt SM; Vermeersch P; De Keersmaecker K
Leukemia; 2019 Feb; 33(2):319-332. PubMed ID: 29930300
[TBL] [Abstract][Full Text] [Related]
3. Ribosomal Lesions Promote Oncogenic Mutagenesis.
Sulima SO; Kampen KR; Vereecke S; Pepe D; Fancello L; Verbeeck J; Dinman JD; De Keersmaecker K
Cancer Res; 2019 Jan; 79(2):320-327. PubMed ID: 30482776
[TBL] [Abstract][Full Text] [Related]
4. The T-cell leukemia related rpl10-R98S mutant traps the 60S export adapter Nmd3 in the ribosomal P site in yeast.
Patchett S; Musalgaonkar S; Malyutin AG; Johnson AW
PLoS Genet; 2017 Jul; 13(7):e1006894. PubMed ID: 28715419
[TBL] [Abstract][Full Text] [Related]
5. Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells.
Kampen KR; Fancello L; Girardi T; Rinaldi G; Planque M; Sulima SO; Loayza-Puch F; Verbelen B; Vereecke S; Verbeeck J; Op de Beeck J; Royaert J; Vermeersch P; Cassiman D; Cools J; Agami R; Fiers M; Fendt SM; De Keersmaecker K
Nat Commun; 2019 Jun; 10(1):2542. PubMed ID: 31186416
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
Maude SL; Dolai S; Delgado-Martin C; Vincent T; Robbins A; Selvanathan A; Ryan T; Hall J; Wood AC; Tasian SK; Hunger SP; Loh ML; Mullighan CG; Wood BL; Hermiston ML; Grupp SA; Lock RB; Teachey DT
Blood; 2015 Mar; 125(11):1759-67. PubMed ID: 25645356
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia.
Sharma ND; Nickl CK; Kang H; Ornatowski W; Brown R; Ness SA; Loh ML; Mullighan CG; Winter SS; Hunger SP; Cannon JL; Matlawska-Wasowska K
Cancer Sci; 2019 Jun; 110(6):1931-1946. PubMed ID: 30974024
[TBL] [Abstract][Full Text] [Related]
8. HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development.
de Bock CE; Demeyer S; Degryse S; Verbeke D; Sweron B; Gielen O; Vandepoel R; Vicente C; Vanden Bempt M; Dagklis A; Geerdens E; Bornschein S; Gijsbers R; Soulier J; Meijerink JP; Heinäniemi M; Teppo S; Bouvy-Liivrand M; Lohi O; Radaelli E; Cools J
Cancer Discov; 2018 May; 8(5):616-631. PubMed ID: 29496663
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia.
Porcu M; Kleppe M; Gianfelici V; Geerdens E; De Keersmaecker K; Tartaglia M; Foà R; Soulier J; Cauwelier B; Uyttebroeck A; Macintyre E; Vandenberghe P; Asnafi V; Cools J
Blood; 2012 May; 119(19):4476-9. PubMed ID: 22438252
[TBL] [Abstract][Full Text] [Related]
10. IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies.
Gianfelici V; Messina M; Paoloni F; Peragine N; Lauretti A; Fedullo AL; Di Giacomo F; Vignetti M; Vitale A; Guarini A; Chiaretti S; Foà R
Leuk Lymphoma; 2019 Mar; 60(3):829-832. PubMed ID: 30188230
[No Abstract] [Full Text] [Related]
11. Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesis.
Sulima SO; Patchett S; Advani VM; De Keersmaecker K; Johnson AW; Dinman JD
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):5640-5. PubMed ID: 24706786
[TBL] [Abstract][Full Text] [Related]
12. JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.
Delgado-Martin C; Meyer LK; Huang BJ; Shimano KA; Zinter MS; Nguyen JV; Smith GA; Taunton J; Winter SS; Roderick JR; Kelliher MA; Horton TM; Wood BL; Teachey DT; Hermiston ML
Leukemia; 2017 Dec; 31(12):2568-2576. PubMed ID: 28484265
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Atak ZK; Li N; Vicente C; Patchett S; Girardi T; Gianfelici V; Geerdens E; Clappier E; Porcu M; Lahortiga I; Lucà R; Yan J; Hulselmans G; Vranckx H; Vandepoel R; Sweron B; Jacobs K; Mentens N; Wlodarska I; Cauwelier B; Cloos J; Soulier J; Uyttebroeck A; Bagni C; Hassan BA; Vandenberghe P; Johnson AW; Aerts S; Cools J
Nat Genet; 2013 Feb; 45(2):186-90. PubMed ID: 23263491
[TBL] [Abstract][Full Text] [Related]
14. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
15. Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells.
Verbelen B; Girardi T; Sulima SO; Vereecke S; Verstraete P; Verbeeck J; Royaert J; Cinque S; Montanaro L; Penzo M; Imbrechts M; Geukens N; Geuens T; Dierckx K; Pepe D; Kampen K; De Keersmaecker K
Eng Life Sci; 2022 Feb; 22(2):100-114. PubMed ID: 35140557
[TBL] [Abstract][Full Text] [Related]
16. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
[TBL] [Abstract][Full Text] [Related]
17. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
18. Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.
Waldmann TA; Chen J
Annu Rev Immunol; 2017 Apr; 35():533-550. PubMed ID: 28182501
[TBL] [Abstract][Full Text] [Related]
19. JAK/STAT signaling in hematological malignancies.
Vainchenker W; Constantinescu SN
Oncogene; 2013 May; 32(21):2601-13. PubMed ID: 22869151
[TBL] [Abstract][Full Text] [Related]
20. SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms.
Lahera A; López-Nieva P; Alarcón H; Marín-Rubio JL; Cobos-Fernández MÁ; Fernández-Navarro P; Fernández AF; Vela-Martín L; Sastre I; Ruiz-García S; Llamas P; López-Lorenzo JL; Cornago J; Santos J; Fernández-Piqueras J; Villa-Morales M
Br J Haematol; 2023 May; 201(4):718-724. PubMed ID: 36786170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
